期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脐带间充质干细胞治疗儿童异基因造血干细胞移植后急性移植物抗宿主病疗效观察 被引量：10

Curative Effect of Human Umbilical Cord Mesenchymal Stem Cells for Treatment of Acute Graft-versus-host Disease of Children after Allo-HSCT
暂未订购
导出
摘要 本研究观察人脐带间充质干细胞(MSC)治疗儿童急性移植物抗宿主病的疗效和安全性。用胶原酶消化法分离培养人脐带间充质干细胞,进行传代培养、扩增,培养至第3-5代用于临床治疗;5例急性白血病患儿经化疗达完全缓解。2例行亲缘HLA3/6位点相合的骨髓造血干细胞移植,1例行同胞HLA全相合骨髓与外周血造血干细胞联合移植,1例行无血缘关系HLA4/6位点相合双份脐血造血干细胞移植,1例行无血缘关系HLA5/6位点相合单份脐血造血干细胞移植。患儿发生Ⅲ-Ⅳ度急性移植物抗宿主病(aGVHD),接受二线免疫抑制治疗无效后,行0.5×106/kg受者体重MSC治疗。结果表明,5例急性白血病患儿均获造血重建,并发生皮肤、肝脏和胃肠道Ⅲ-Ⅳ度aGVHD,经二线免疫抑制治疗无效,输注人脐带间充质干细胞治疗后,皮疹消退,肝功能恢复正常,胃肠道症状好转。患儿均未发生输注相关不良反应。目前患儿均无原发病的复发,均处于无病生存状态。结论:异基因造血干细胞移植是治疗儿童急性白血病的有效方法,脐带间充质干细胞治疗儿童急性移植物抗宿主病是安全有效的。 This study was aimed to investigate the curative effect and safety of human umbilical cord mesenchymal stem cells （hUCMSC） to treat acute graft-versus-host disease （aGVHD） of children after hematopoietic stem cell transplantation（HSCT）. HUCMSC were isolated and cultured by collagenase digestion and passage culture. The 3rd to the 5th passage of hUCMSC were used for clinical treatment. Five cases of children acute leukemia achieved complete remission after chemotherapy. Two cases received HLA 3/6 loci matched haploidenticai bone marrow HSCT. One case received HLA-matched sibling bone marrow and peripheral blood HSCT. One case received unrelated HLA 4/6 loci matched umbilical cord blood HSCT. One case received unrelated HLA 5/6 loci matched umbilical cord blood HSCT. The children received e therapy after Ⅲ - IV aGVHD occurring. They received 0.5 x 10^6/kg hUCM- SC infusion when conventional therapy was ineffective. The results showed that 5 cases of children acute leukemia a- chieved hematopoietic reconstitution and developed the Ⅲ - 1V grade aGVHD. The five cases of children were infused with hUCMSC. The rash subsided, the liver function was normalized and the gastrointestinal symptoms were improved. The infusion-related adverse reaction did not happen. At present, the 5 children are in remission. It is concluded that allogeneic HSCT is an effective therapeutic method for children with acute leukemia. HUCMSC infusion can be safely and effectivelv used for the treatment of refractory aGVHD.
作者 乔淑敏 陈广华 王易 胡绍燕 孙绪丁 吴德沛
机构地区 苏州大学附属第一医院 苏州大学附属儿童医院血液科 济宁市第一人民医院儿科
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2013年第3期716-720,共5页 Journal of Experimental Hematology
基金 江苏省临床医学研究中心项目(编号BL2012005) 江苏省卫生厅面上项目(H201212) 江苏省临床医学中心血液病学开放课题(编号KF200943)
关键词 脐带间充质干细胞 异基因造血干细胞移植 急性移植物抗宿主病 umbilical cord mesenchymal stem cell allogeneic hematopoietic stem cell transplantation acute graftversus-host disease
分类号 R457.7 [医药卫生—治疗学]
  • 相关文献

参考文献12

  • 1Ringden O, Le Blanc K. Mesenchymal stem cells for treatment of a- cute and chronic graft-versus-host disease, tissue toxicity and hemor- rhages. Clin Haematol, 2011; 1 (24) :65 -72.
  • 2Ringden 0, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplan- tation ,2006 ;81 (10) : 1390 - 1397.
  • 3陈广华,杨婷,田竤,乔曼,刘慧文,傅琤琤,苗瞄,金正明,唐晓文,韩悦,何广胜,张旭辉,马骁,陈峰,胡晓慧,薛胜利,王荧,仇慧英,孙爱宁,陈志哲,吴德沛.脐带间充质干细胞治疗糖皮质激素耐药的严重型急性移植物抗宿主病19例分析[J].中华血液学杂志,2012,33(4):303-306. 被引量：12
  • 4杨婷,陈广华,薛胜利,乔曼,刘慧文,田竑,乔淑敏,陈峰,陈志哲,孙爱宁,吴德沛.无血清和含胎牛血清培养基培养的脐带间充质干细胞生物学特性比较研究[J].中华血液学杂志,2012,33(9):715-719. 被引量：8
  • 5Lazarus HM, Koc ON, Devine SM, et al. Cotransplantations of HLA i- dentical sibling culture-expanded mesenchymal stem ceils and hema- topoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 2005 ; 11 ( 5 ) : 389 - 398.
  • 6Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal ceils suppress T-lymphocyte proliferation induced by cellularor nonspecific mitogenic stimuli. Blood, 2002 ; 99 ( 10 ) : 3838 - 3843.
  • 7Aggarwai S, Pittenger MF. Human mesenchymal stem ceils modulate allogeneie immune cell responses. Blood, 2005 ; 105 (4) : 1815 - 1822.
  • 8Le Blanc K, Rasmusson I, Sundberg B, et al. Human mesanchymal stem ceils support unrelated donor hematopoietic steam cells and sup- press T cell activation. Bone Marrow Transplant, 2004; 33 (6) :597 - 604.
  • 9Prasad VK, Lucas KG, Kleiner GI, et al. Efficacy and safety of ex- vivo cultured adult human mesenchymal stem cells (prochymai (TM) ) in pediatric patients with severe refractory acute graft-versus- host disease in a compassionate use study. Biol Blood Marrow Trans- plant, 2011 ; 17(4) :534 -541.
  • 10Pavletic SZ, Martin P, and Lee S J, et al. Measuring therapeutic re- sponse in chronic graft - versus - host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Biol Blood Marrow Trans- plant, 2006; 12(3) :252 -266.

二级参考文献27

  • 1Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenehymal stem cells. Science, 1999,284 : 143-147.
  • 2Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 2006, 8: 315-317.
  • 3Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stern ceils with hematopoiesis- supportive function and other potentials. Haematologica,2006,91 : 1017-1026.
  • 4Weiss ML, Anderson C, Medicetty S, et al. Immune properties of human umbilical cord wharton' s jelly-derived ceils. Stem Cells, 2008, 26:2865-2874.
  • 5Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host dis- ease: a phase II study. Lancet,2008, 371: 1579-1586.
  • 6MacMillan ML, Blazar BR, DeFor TE, et al. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelat- ed donor umbilical cord blood : results of a phase I-II clinical trial. Bone Marrow Transplant. 2009. 43 : 447-454.
  • 7Spees JL, Gregory CA, Singh H, et al. Internalized antigens must be removed to prepare hypoimmunogenie mesenchymal stem eeUs for cell and gene therapy. Mol Ther,2004,9: 747-756.
  • 8Sundin M, Ringdon O, Sundberg B, et al. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneie hematopoietic stem cell recipients. Haematologica, 2007, 92 : 1208-1215.
  • 9Koeaoemer A, Kern S, Kluter H, et al. Human AB serum and thrombin-aetivated platelet-rieh plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells, 2007,25:1270-1278.
  • 10l)oucet C, Ernou I, Zhang Y, et al. Platelet lysates promote mesenchymal stem cell expansion- a safety substitute for animal. serum in cell-based therapy applications. J Cell Physiol, 2005, 205:228-236.

共引文献18

同被引文献89

引证文献10

二级引证文献38

中国实验血液学杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部